Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextromethorphan Augmentation in Treatment-Resistant Schizophrenia
NCT05944510Phase 4Completed
- Sponsor
- AIIMS New Delhi
- Start
- Aug 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in schizophrenia comparing Add-on Dextromethorphan with Add-on Placebo (2 arms). Primary endpoint: Positive and Negative Syndrome Scale at 12 weeks. Started Aug 2023; status: completed.
02
Drugs
dextromethorphan
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT05944510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05944510.